FMT
TGTX icon

First Mercantile Trust’s TG Therapeutics TGTX Stock Holding History

First Mercantile Trust’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$94K Buy
2,830
+63
+2% +$1.95K 0.01% 670
2021
Q2 		$107K Buy
2,767
+801
+41% +$31.5K 0.01% 663
2021
Q1 		$95K Sell
1,966
-1,856
-49% -$89.2K 0.01% 693
2020
Q4 		$199K Sell
3,822
-1,015
-21% -$34.3K 0.02% 422
2020
Q3 		$140K Buy
+4,837
New +$111K 0.02% 555
2019
Q1 		– Sell
-12,858
Closed -$53K – 922
2018
Q4 		$53K Sell
12,858
-698
-5% -$3.47K 0.01% 765
2018
Q3 		$76K Sell
13,556
-6,667
-33% -$76.2K 0.01% 752
2018
Q2 		$266K Sell
20,223
-5,443
-21% -$74.9K 0.05% 414
2018
Q1 		$364K Sell
25,666
-1,035
-4% -$13.2K 0.08% 321
2017
Q4 		$219K Buy
26,701
+5,938
+29% +$51.9K 0.04% 511
2017
Q3 		$246K Buy
20,763
+1,584
+8% +$18K 0.04% 510
2017
Q2 		$193K Buy
19,179
+12,779
+200% +$143K 0.03% 578
2017
Q1 		$75K Buy
+6,400
New +$45.9K 0.01% 768

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Mercantile Trust's TGTX Position: Q3 2021 in Review

First Mercantile Trust increased its TG Therapeutics (TGTX) stake by 2.3% in Q3 2021, buying an estimated $1.95K and bringing the position to 2,830 shares worth $94K. The position accounts for 0.01% of the portfolio, ranked #670.

First Mercantile Trust first reported a position in TGTX in Q1 2017 and has held it in 13 quarters since. The position peaked at $364K in Q1 2018. 222 funds tracked by Wall St. Rank hold TGTX as of Q3 2021.

  • First Mercantile Trust held 2,830 shares of TG Therapeutics worth $94K as of Q3 2021.
  • First Mercantile Trust bought 63 TG Therapeutics shares in Q3 2021, an estimated $1.95K.
  • TG Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #670 holding.
  • First Mercantile Trust first reported a position in TG Therapeutics in Q1 2017 and has held it in 13 quarters since.
  • First Mercantile Trust's TG Therapeutics position peaked at $364K in Q1 2018.
  • 222 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.